首页 › 基金 › THIRD AVENUE MANAGEMENT LLC › SUPN
THIRD AVENUE MANAGEMENT LLC 对 SUPN 的持仓历史
SUPERNUS PHARMACEUTICALS · 医疗保健
THIRD AVENUE MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 SUPN(SUPERNUS PHARMACEUTICALS)157,150 股,市值约 US$6.8M,约占其申报组合的 1.14%,在其申报持仓中市值排名第 27 位。 THIRD AVENUE MANAGEMENT LLC 最近 13 个申报季度中有 13 个季度披露了 SUPN 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
THIRD AVENUE MANAGEMENT LLC 对 SUPN 的持仓演变
THIRD AVENUE MANAGEMENT LLC 于 Q3 2023 首次披露 SUPN 持仓:116,549 股(约 US$3.3M)。 该持仓在 Q4 2025 达到峰值 189,493 股,市值约 US$9.4M。 在 13 次申报中,THIRD AVENUE MANAGEMENT LLC 3 次增持、1 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 157,150 股、市值约 US$6.8M,环比增持 4,426 股。。 持仓曾出现大幅变动:Q4 2023 增持约 37% (随后一个季度股价上涨 18%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 116.55K | $3.27M | 新进 |
| Q4 2023 | 159.72K | $4.62M | 增持 |
| Q1 2024 | 159.72K | $5.45M | 持有 |
| Q2 2024 | 189.12K | $5.06M | 增持 |
| Q3 2024 | 189.49K | $5.91M | 持有 |
| Q4 2024 | 189.49K | $6.85M | 持有 |
| Q1 2025 | 189.49K | $6.21M | 持有 |
| Q2 2025 | 189.49K | $5.97M | 持有 |
| Q3 2025 | 189.49K | $9.10M | 持有 |
| Q4 2025 | 189.49K | $9.42M | 持有 |
| Q1 2026 | 152.72K | $7.89M | 减持 |
| Q2 2026 | 152.72K | $7.10M | 持有 |
| Q3 2026 | 157.15K | $6.76M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SUPN 与 13F 数据
SUPN(SUPERNUS PHARMACEUTICALS)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 SUPN,申报仓位最大的包括:MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SUPN 的基金
- MILLENNIUM MANAGEMENT LLC 3.85M 股 · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M 股 · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M 股 · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K 股 · $28.55M · Q2 2026
- Jones Hill Capital LP 601.68K 股 · $25.90M · Q3 2026
- Soleus Capital Management, L.P. 520.00K 股 · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K 股 · $22.80M · Q2 2026
更多关于 THIRD AVENUE MANAGEMENT LLC
常见问题
How long has THIRD AVENUE MANAGEMENT LLC held SUPN?
THIRD AVENUE MANAGEMENT LLC has disclosed SUPN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is THIRD AVENUE MANAGEMENT LLC's current position in SUPN?
As of Q3 2026, THIRD AVENUE MANAGEMENT LLC holds 157.15K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $6.76M, representing 1.14% of its reported portfolio and ranking #27.
Has THIRD AVENUE MANAGEMENT LLC been buying or selling SUPN?
In the latest 13F filing (Q3 2026), THIRD AVENUE MANAGEMENT LLC increased its position in SUPN. The position peaked in Q4 2025 at 189.49K shares.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.